Literature DB >> 20544885

The approaches for manipulating mitochondrial proteome.

Inna N Shokolenko1, Mikhail F Alexeyev, Susan P LeDoux, Glenn L Wilson.   

Abstract

Over the past decade a large volume of research data has accumulated which has established a fundamental role for mitochondria in normal cellular functioning, as well as in various pathologies. Mitochondria play a pivotal role in metabolism and energy production, and are one of the key players involved in programmed cell death. On the other hand, mitochondrial dysfunction is implicated, directly or indirectly in numerous pathological conditions including inherited mitochondrial disorders, diabetes, cardiovascular and neurodegenerative diseases, and a variety of malignancies. The ability to modulate mitochondrial function by altering the diverse protein component of this organelle may be of great value for developing future therapeutic interventions. This review will discuss approaches used to introduce proteins into mitochondria. One group of methods utilizes strategies aimed at expressing proteins from genes in the nucleus. These include overexpression of nuclear-encoded mitochondrial proteins, allotopic expression, which is the re-coding and relocation of mitochondrial genes to the nucleus for expression and subsequent delivery of their gene products to mitochondria, and xenotopic expression, which is the nuclear expression of genes coding electron transport chain components from distant species, for delivery of their products to mammalian mitochondria. Additionally, antigenomic and progenomic strategies which focus on expression of mitochondrially targeted nuclear proteins involved in the maintenance of mtDNA will be discussed. The second group of methods considered will focus on attempts to use purified proteins for mitochondrial delivery. Special consideration has been given to the complexities involved in targeting exogenous proteins to mitochondria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544885      PMCID: PMC3249350          DOI: 10.1002/em.20570

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  99 in total

1.  Targeting DNA repair proteins to mitochondria.

Authors:  Allison W Dobson; Mark R Kelley; Glenn L Wilson; Susan P LeDoux
Journal:  Methods Mol Biol       Date:  2002

2.  Targeting proteins to mitochondria using TAT.

Authors:  Victoria Del Gaizo; James A MacKenzie; R Mark Payne
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

3.  Cytochromes c1 and b2 are sorted to the intermembrane space of yeast mitochondria by a stop-transfer mechanism.

Authors:  B S Glick; A Brandt; K Cunningham; S Müller; R L Hallberg; G Schatz
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

4.  Stable transformation of CHO Cells and human NARP cybrids confers oligomycin resistance (oli(r)) following transfer of a mitochondrial DNA-encoded oli(r) ATPase6 gene to the nuclear genome: a model system for mtDNA gene therapy.

Authors:  S J Zullo; W T Parks; M Chloupkova; B Wei; H Weiner; W A Fenton; J M Eisenstadt; C R Merril
Journal:  Rejuvenation Res       Date:  2005       Impact factor: 4.663

5.  The alternative oxidase, a tool for compensating cytochrome c oxidase deficiency in human cells.

Authors:  Emmanuel P Dassa; Eric Dufour; Sergio Goncalves; Howard T Jacobs; Pierre Rustin
Journal:  Physiol Plant       Date:  2009-04-25       Impact factor: 4.500

6.  Endonuclease III and endonuclease VIII conditionally targeted into mitochondria enhance mitochondrial DNA repair and cell survival following oxidative stress.

Authors:  Lyudmila I Rachek; Valentina I Grishko; Mikhail F Alexeyev; Viktoriya V Pastukh; Susan P LeDoux; Glenn L Wilson
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

7.  Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression.

Authors:  Shilpa Iyer; Ravindar R Thomas; Francisco R Portell; Lisa D Dunham; Caitlin K Quigley; James P Bennett
Journal:  Mitochondrion       Date:  2009-02-04       Impact factor: 4.160

8.  Developing a genetic approach to investigate the mechanism of mitochondrial competence for DNA import.

Authors:  Frédérique Weber-Lotfi; Noha Ibrahim; Pierre Boesch; Anne Cosset; Yuri Konstantinov; Robert N Lightowlers; André Dietrich
Journal:  Biochim Biophys Acta       Date:  2008-11-12

Review 9.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.

Authors:  Frederic Heitz; May Catherine Morris; Gilles Divita
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

10.  Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.

Authors:  Michal Minczuk; Monika A Papworth; Jeffrey C Miller; Michael P Murphy; Aaron Klug
Journal:  Nucleic Acids Res       Date:  2008-05-29       Impact factor: 16.971

View more
  4 in total

Review 1.  Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharm Res       Date:  2011-08-27       Impact factor: 4.200

Review 2.  Mitochondrial subversion in cancer.

Authors:  Aditi Chatterjee; Santanu Dasgupta; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

Review 3.  Mitochondria as a target of environmental toxicants.

Authors:  Joel N Meyer; Maxwell C K Leung; John P Rooney; Ataman Sendoel; Michael O Hengartner; Glen E Kisby; Amanda S Bess
Journal:  Toxicol Sci       Date:  2013-04-29       Impact factor: 4.849

4.  Leber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to Bedside.

Authors:  Rajeshwari D Koilkonda; John Guy
Journal:  J Ophthalmol       Date:  2010-12-26       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.